Related Experiment Videos

Danaparoid: an anti-thrombotic agent without major impact on triglyceride hydrolysis capacity in humans

D P Mikhailidis, I A Jagroop

Journal of Internal Medicine

|March 30, 1999

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Endocrine Disorders and Peripheral Arterial Disease - A Series of Reviews Cushing Syndrome-Cortisol Excess.

Current vascular pharmacology·2023

Growth Hormone, Atherosclerosis and Peripheral Arterial Disease: Exploring the Spectrum from Acromegaly to Growth Hormone Deficiency.

Current vascular pharmacology·2023

Nonalcoholic Fatty Pancreas Disease: Role in Metabolic Syndrome, "Prediabetes," Diabetes and Atherosclerosis.

Digestive diseases and sciences·2021

Multifocal arterial disease: clinical implications and management.

Current opinion in cardiology·2020

Daylight saving time and myocardial infarction: should we be worried? A review of the evidence.

European review for medical and pharmacological sciences·2018

Mean Platelet Volume as a Surrogate Marker for Platelet Activation in Patients With Idiopathic Pulmonary Fibrosis.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2015

See all related articles